Updates are available Correction dated 2021-09-08
Click to view Correction: https://doi.org/10.1186/s12864-021-07942-2
-
Authors
Bian, Xingchen
Liu, Xiaofen
Zhang, Xuefei
Li, Xin
Zhang, Jing
Zheng, Huajun
Song, Sichao
Li, Xiang
Feng, Meiqing
-
Funding
Funding for this research was provided by:
Scientific and Innovative Action Plan of Shanghai (19431903000, 19411964900)
National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology (2017ZX09304005)
Shanghai Municipal Commission of Health and Family Planning (ZY (2018-2020)-FWTX-1108)
- License Information
-
More Information
Article History
Received: 2 October 2020
Accepted: 24 June 2021
First Online: 12 July 2021
Change Date: 8 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12864-021-07942-2
Declarations
:
: The clinical trial (registration number: NCT01940731) has been approved by Huashan Institutional Review Board affiliated to Fudan University. Collecting samples were permitted. Samples used in this study all belong to The Culture Collection of Institute of Antibiotics, Huashan Hospital. The Informed Consent Form was waived by Huashan Institutional Review Board if using strains for further study from The Culture Collection. Personal privacy is not involved in this study.
: Not applicable.
: There is no conflict of interest.
